Countdown to SLAS Europe: ThirdLaw Molecular Inc.
https://t.co/ysNtkbcz5E
Organised by the Society for Laboratory Automation and Screening (SLAS), SLAS Europe currently is taking place in Hamburg from 20–22 May. As part of a special series, European Biotechnology Magazin...
Our own DJ Bernsteel at @SLAS_Org Europe 2025 as part of the Innovation AveNEW program.
📍 Hamburg, Germany
📅 May 20–22, 2025
🧬Screening a 4.5 billion-member DNA-encoded library to identify protein binders using our proprietary SYMBA-DEL™ engine. https://t.co/rS018ghajs
New spiroligomer molecules can ‘change medicine’
ThirdLaw Molecular is developing a new class of therapeutic molecules with potential to address age-related deterioration.
#longevity#biotech#drugdevelopment#pharma
https://t.co/8FTioT1a5d
Nearly 𝟵𝟬% 𝗼𝗳 𝗽𝗿𝗼𝘁𝗲𝗶𝗻𝘀 are considered "undruggable", limiting our ability to treat many diseases.
Read about our programmable molecules that are the 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼f 𝘂𝗻𝗱𝗿𝘂𝗴𝗴𝗮𝗯𝗹𝗲 𝘁𝗮𝗿𝗴𝗲𝘁 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 @Tech_Networks
https://t.co/6Jgj6Lpcrn
Check out our feature article in The @medicine_maker – Meet the Goldilocks Molecules! 🚀 🔗 Read the full Q&A to learn how we're unlocking 𝗻𝗲𝘄 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗽𝗼𝘀𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀: https://t.co/YbNl0FKHtg #molecules
Imagine a world where the boundaries between #biologics and #smallmolecules disappear, unlocking new possibilities for diagnosing and treating disease.
📷 Read the full article in the @PHLBizJournal to learn about the technology! https://t.co/Kud5ftpodE #futureofmedicine
🎉 Congratulations to the ThirdLaw Molecular Team! Spiroligomer™ macromolecules—a breakthrough technology that has the potential to revolutionize drug discovery, featured in @PHLBizJournal https://t.co/Kud5ftpodE #molecules#drugdiscovery#futureofmedicine
🚀 Today we launch the platform for targeted drug discovery featuring a DNA-encoded library of 4.5 billion Spiroligomer™ macromolecules! 🧬 This marks a new era in molecular therapeutics.
Release here https://t.co/mXKcz6Xgla #DrugDiscovery#MolecularTherapeutics#Innovation